• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Bob S. Carter, M.D. Ph.D.

Associate Professor, Department of Surgery, Harvard Medical School

Associate Professor, Neurosurgery, Massachusetts General Hospital

Contact Info

Bob Carter
Massachusetts General Hospital
55 Fruit Street

Boston, MA, 02114
Mailstop: Pappas Center for Neuro-Oncology
Phone: 617-726-3360
Fax: 617-726-3365
Email not available

Assistant

Sharon Tozier
Administrative Assistant
Neurosurgery
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Mailstop: Yawkey 9043
Phone: 617-726-3360
Fax: 617-726-3365
stozier@partners.org

DF/HCC Program Affiliation

Neuro-Oncology

Research Abstract

Our laboratory is interested in the use of gene transfer techniques for the treatment of brain tumors. Three major areas of interest are: genetic modification of T-cells with chimeric T-cell receptors to target human glioma, serum biomarkers for glioma, and multimodality therapy (anti-angiogenic, radiation, and chemotherapy) approaches to glioma.

Publications

  • Bullain SS,Sahin A,Szentirmai O,Sanchez C,Lin N,Baratta E,Waterman P,Weissleder R,Mulligan RC,Carter BS.Genetically engineered T cells to target EGFRvIII expressing glioblastoma.J Neurooncol 2009 Apr 23.
    19387557
  • Aghi MK,Carter BS,Cosgrove GR,Ojemann RG,Amin-Hanjani S,Martuza RL,Curry WT Jr,Barker FG 2nd.Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.Neurosurgery 2009 Jan;64(1):56-60;
    19145156
  • Skog J,Wurdinger T,van Rijn S,Meijer DH,Gainche L,Sena-Esteves M,Curry WT Jr,Carter BS,Krichevsky AM,Breakefield XO.Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.Nat Cell Biol 2008 Dec;1
    19011622
  • Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S, Kung AL, Mulligan RC, Carter BS.Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and
    16462491
  • Niederman TM, Ghogawala Z, Carter BS, Tompkins HS, Russell MM, Mulligan RC.Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.Proc Natl Acad Sci U S A 2002 May 14;99(10):7009-14.
    11997459
  • Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young JA.A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.J
    11000224
  • Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, Krieger JE, Manseau EJ, Harvey VS, Eckelhoefer IA, Feng D, Dvorak AM, Mulligan RC, Dvorak HF.Heterogeneity of the angiogenic response induced in different normal adult tissues by
    10653008
  • Carter BS, Zervas NT, Chiocca EA.Neurogenetic surgery: current limitations and the promise of gene- and virus-based therapies.Clin Neurosurg 1999;45:226-46.
    10461522